Latest Shinya Yamanaka Stories
Connie K. Ho for redOrbit.com For the first time, scientists at Gladstone Institute have changed skin cells, imbued with a single genetic factor, into cells that can become a group of interconnecting, functional brain cells. The findings show that there may be options in combating neurological conditions. This transformation of cells would pave the way for better methods in testing drugs for neurodegenerative conditions like Alzheimer’s disease. The research follows increased interest...
Medical breakthrough holds promise for millions with heart failure Scientists at the Gladstone Institutes today are announcing a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks—by converting scar-forming cardiac cells into beating heart muscle. These scientists previously transformed such cells into cardiac muscle-like cells in petri dishes. But Gladstone postdoctoral scholar Li Qian, PhD, along with researchers in the laboratory of...
MADISON, Wis., March 28, 2012 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced an expansion of its existing distribution agreement with iPS Academia Japan, Inc. to include iCell® Neurons and iCell Endothelial Cells. The original distribution agreement, announced on June 8, 2011, covered the distribution of CDI's iCell Cardiomyocytes, the first commercially available product based on induced pluripotent stem cells (iPSCs), in Japan. CDI is the...
ST. LOUIS, Mo., Feb. 21, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, has furthered its commitment to stem cell research, drug discovery and ADME/Toxicology by acquiring a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio. Sigma Life Science, leveraging its zinc finger protein platform and stem cell technology...
BRONX, N.Y., Oct. 24, 2011 /PRNewswire-USNewswire/ -- Shinya Yamanaka, M.D., Ph.D., the internationally renowned scientist known for his pioneering work generating the first induced pluripotent stem cells (iPS cells), delivered the 2011 Lasker Lecture at Albert Einstein College of Medicine of Yeshiva University today. A standing-room-only crowd was on-hand for his presentation covering his initial groundbreaking research with iPS cells and his ongoing research in the field. The Lasker...
Breakthrough discovery is likely to advance medicine and human healthA scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.In a paper being published online today in the scientific journal Cell Stem Cell, Sheng Ding, PhD, reveals efficient and robust methods for transforming adult skin cells into neurons...
MADISON, Wis., June 8, 2011 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced an agreement with iPS Academia Japan, Inc., who will distribute CDI's iCell® Cardiomyocytes, the first commercially available product based on induced pluripotent stem cells (iPSCs), in Japan. This distribution agreement brings the vision of the two pioneers of iPSC technology, Dr. James Thomson and Dr. Shinya Yamanaka, a step closer to making the technology widely available to...
Discoveries will advance medicine and human healthA scientist at the Gladstone Institutes has made two significant stem-cell discoveries that advance medicine and human health by creating powerful new approaches for using stem cells and stem-cell-like technology.In two papers being published on April 25 in the Proceedings of the National Academy of Sciences, Sheng Ding, PhD, reveals novel and safer methods not only for transforming embryonic stem cells into large numbers of brain cells with...
The annual Albany Medical Center Prize in Medicine and Biomedical Research award has been given to three stem cell researchers for their work in human stem cells. The winners are Elaine Fuchs of Rockefeller University in New York City, James A. Thomson of the University of Wisconsin-Madison School of Medicine and Public Health and Shinya Yamanaka of Kyoto University in Japan. The researchers will share $500,000, which is the largest award in medicine and science in the U.S. Morris "Marty"...
ALBANY, N.Y., March 16, 2011 /PRNewswire-USNewswire/ -- Three scientists whose pioneering work in isolating human stem cells holds great promise for the future of medicine have been named the recipients of the 11th annual Albany Medical Center Prize in Medicine and Biomedical Research. They are: Elaine Fuchs, Ph.D., the Rebecca C. Lancefield Professor, head of the Laboratory of Mammalian Cell Biology and Development, and a Howard Hughes Medical Institute investigator at The Rockefeller...
